Temozolomide resistant MGMT negative/MMR proficient cancer cells rely on ATR signaling and homologous recombination for DNA repair and survival

被引：0
|
作者：
El Touny, Lara [1 ]
Harris, Erik [1 ]
Hose, Curtis [1 ]
Connelly, John [1 ]
Vengsarkar, Diana [1 ]
Monks, Anne [1 ]
Parchment, Ralph E. [1 ]
Doroshow, James H. [2 ]
Teicher, Beverly A. [2 ]
Rapisarda, Annamaria [1 ]
机构：
[1] FNLCR Leidos Biomed Res Inc, Frederick, MD USA
[2] NCI, NIH, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-270
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
270
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Rare Stochastic Expression of O6-Methylguanine-DNA Methyltransferase (MGMT) in MGMT-Negative Melanoma Cells Determines Immediate Emergence of Drug-Resistant Populations upon Treatment with Temozolomide In Vitro and In Vivo
    Chen, Thomas C.
    Chan, Nymph
    Minea, Radu O.
    Hartman, Hannah
    Hofman, Florence M.
    Schonthal, Axel H.
    CANCERS, 2018, 10 (10)
  • [42] ent-Kaurane-Type Diterpenes Induce ROS-Mediated Mitochondrial Dysfunction and Apoptosis by Suppress the Homologous Recombination DNA Repair in Triple-Negative Breast Cancer Cells
    Xie, Yikun
    Su, Yifan
    Liao, Zirou
    Liang, Xinran
    Hua, Jing
    Zhang, Dawei
    Hu, Dexuan
    Yu, Qian
    CHEMISTRY & BIODIVERSITY, 2023, 20 (08)
  • [43] mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer
    Mo, Wei
    Liu, Qingxin
    Lin, Curtis Chun-Jen
    Dai, Hui
    Peng, Yang
    Liang, Yulong
    Peng, Guang
    Meric-Bernstam, Funda
    Mills, Gordon B.
    Li, Kaiyi
    Lin, Shiaw-Yih
    CLINICAL CANCER RESEARCH, 2016, 22 (07) : 1699 - 1712
  • [44] Progression-free and overall survival in newly-diagnosed homologous recombination DNA-repair deficient ovarian cancer without a BRCA mutation
    Graves, Stephen
    Sullivan, Mackenzie
    Adkoli, Anusha
    Zhou, Qin
    Chi, Dennis
    Ellenson, Lora
    O'Cearbhaill, Roisin
    Weigelt, Britta
    Grisham, Rachel
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S43 - S44
  • [45] SENP5 promotes homologous recombination-mediated DNA damage repair in colorectal cancer cells H2AZ
    Liu, Tingting
    Wang, Hang
    Chen, Yuanyuan
    Wan, Zhijie
    Du, Zhipeng
    Shen, Hui
    Yu, Yue
    Ma, Shengzhe
    Xu, Ying
    Li, Zhuqing
    Yu, Nanxi
    Zhang, Fangxiao
    Cao, Kun
    Cai, Jianming
    Zhang, Wei
    Gao, Fu
    Yang, Yanyong
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [46] Inhibition of Both EGFR and IGF1R Sensitized Prostate Cancer Cells to Radiation by Synergistic Suppression of DNA Homologous Recombination Repair
    Wang, Yong
    Yuan, Jian Lin
    Zhang, Yun Tao
    Ma, Jian Jun
    Xu, Peng
    Shi, Chang Hong
    Zhang, Wei
    Li, Yu Mei
    Fu, Qiang
    Zhu, Guang Feng
    Xue, Wei
    Lei, Yong Hua
    Gao, Jing Yu
    Wang, Juan Ying
    Shao, Chen
    Yi, Cheng Gang
    Wang, He
    PLOS ONE, 2013, 8 (08):
  • [47] Docetaxel and Carboplatin for the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer and Biallelic Inactivation of Genes in the Homologous Recombination DNA Repair Pathway: The ABCD Trial
    Raychaudhuri, Ruben
    Dejong, Makayla
    Rettig, Matthew
    Yu, Evan Y.
    Gulati, Roman
    Schweizer, Michael T.
    Nelson, Peter S.
    Pritchard, Colin C.
    Montgomery, Bruce
    Cheng, Heather H.
    EUROPEAN UROLOGY, 2025, 87 (03) : 375 - 376
  • [48] PROfound: A randomized Phase III trial evaluating olaparib in patients with metastatic castration-resistant prostate cancer and a deleterious homologous recombination DNA repair aberration
    Bono, J. D.
    Hussain, M.
    Thiery-Vuillemin, A.
    Mateo, J.
    Sartor, O. A.
    Chi, K.
    Fizazi, K.
    Twardowski, P.
    Agarwal, N.
    Sandhu, S.
    Olmos, D.
    Shore, N.
    Saad, F.
    Liu, S.
    Goessl, C.
    Burgents, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 79 - 80
  • [49] Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    Evans, Rachel
    Hawkins, Neil
    Dequen-O'Byrne, Pascale
    McCrea, Charles
    Muston, Dominic
    Gresty, Christopher
    Ghate, Sameer R.
    Fan, Lin
    Hettle, Robert
    Abrams, Keith R.
    de Bono, Johann
    Hussain, Maha
    Agarwal, Neeraj
    TARGETED ONCOLOGY, 2021, 16 (05) : 613 - 623
  • [50] Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    Rachel Evans
    Neil Hawkins
    Pascale Dequen-O’Byrne
    Charles McCrea
    Dominic Muston
    Christopher Gresty
    Sameer R. Ghate
    Lin Fan
    Robert Hettle
    Keith R. Abrams
    Johann de Bono
    Maha Hussain
    Neeraj Agarwal
    Targeted Oncology, 2021, 16 : 613 - 623
12345